在二级AML中验证ICC等级分类
Enrico Attardi1, Marta Cipriani2, Luca Guarnera3
1University of Rome Tor Vergata, Rome, Italy.
Blood advances
|March 5, 2026
概括
二次性急性髓性白血病 (AML) 和骨髓质综合征/AML (MDS/AML) 的遗传特征可以改进风险分层. 国际共识分类 (ICC) 和TP53等特定突变影响预后,指导治疗决策.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 二次性急性髓性白血病 (AML) 是一个异质的疾病群体,预后不佳.
- 以前的病史和遗传特征显著影响AML的结果.
- 国际共识分类 (ICC) 为分类骨髓瘤瘤提供了一个框架.
研究的目的:
- 评估遗传特征与血清细胞计数和AML和MDS/AML患者病史的关联.
- 探索不同ICC类别的生物和预后影响.
- 完善风险分层,指导二次性AML的治疗决策.
主要方法:
- 对924名患有MDS/AML或由ICC分类的AML患者队列的分析.
- 基于遗传特征的分类:"突变TP53"",与肌肉发育相关的 (MDR) 基因突变"",MDR细胞遗传异常"",与治疗相关的AML (t-AML) "和"其他未指明的" (NOS) AML.
- 在不同的ICC类别和AML二级定义中比较生存结果和突变概况.
主要成果:
- "突变TP53"和"MDR-细胞遗传异常"AML/MDS-AML显示出类似的生物学和预后,无论爆发数量如何.
- 具有"MDR基因突变"的MDS/AML和NOS AML表现出不同的遗传特征,在STAG2,SRSF2,ASXL1和TET2中具有更高的突变,与AML相比,与更好的生存相关.
- 之前的MDS史没有影响ICC定义的AML类别内的预后;AML后MDS主要属于ELN 2022的不良风险组.
- 与治疗相关的AML (t-AML) 显示异质的ELN配置文件和不同的整体存活率.
结论:
- 遗传特征和ICC分类有效地捕捉了二次AML和MDS/AML中的疾病生物学.
- 这些分类改进了风险分层,并有助于治疗决策.
- 特定的基因突变和ICC类别对于了解预后和指导治疗至关重要.
更多相关视频
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
12.5K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.9K
相关概念视频
Classification of Leukocytes
6.8K
Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
6.8K
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
